Stock News

Consumer groups, unions urge caution on $63 billion AbbVie deal for Allergan
Allergan Shareholder Meetings Scheduled for October 14, 2019
U.S. judge denies bid to dismiss claim opioids are a public nuisance
Allergan and Molecular Partners Announce Acceptance of U.S. FDA Biologics License Application and Validation of EMA Marketing Authorisation for Abicipar pegol in Patients with Neovascular (Wet) Age-related Macular Degeneration
UPDATE 1-Mallinckrodt to pay $24 mln in cash to settle opioid lawsuits with two Ohio counties

As seen on...